SAN CLEMENTE, Calif., May 12 /PRNewswire/ -- USGI Medical, Inc. (USGI), the leader in incisionless surgery, announced today that the company has licensed its incisionless surgery technology to Intuitive Surgical (Nasdaq: ISRG) for use in medical robotics applications. Financial terms of the deal were not disclosed.
"We've been impressed by USGI's technical and clinical development including their intellectual property," said Gary Guthart, president and chief operating officer of Intuitive Surgical Inc. "The combination of USGI's intellectual property with Intuitive's robotic capabilities allows for compelling possibilities for future robotic products."
USGI's incisionless surgery platform, the EndoSurgical Operating System(TM) (EOS), is designed to address a wide range of surgical indications. Surgeons and gastroenterologists currently use the EOS to perform endolumenal (procedures within the GI tract) and translumenal procedures through the body's natural orifices (these are commonly referred to as "NOTES" or Natural Orifice Translumenal Endoscopic Surgery). Eliminating skin incisions may reduce the risk of infection and associated complications and may result in less post-operative pain, faster recovery time and no abdominal scars for patients.
"This agreement with Intuitive Surgical is another step forward in our efforts to establish the EOS as the leading, most complete surgical platform for Incisonless Surgery," said USGI Medical CEO Eugene Chen. "Many of the country's leading physicians have used the EOS to complete a wide range of groundbreaking incisionless procedures. We believe that mechanical and robotic solutions complement each other and together will advance and expand this field to a wider group of procedures and patients."
Surgeons have used USGI's EOS to complete the first transgastric gall
bladder and appendix removals in the U.S. and to close the access incision
(gastrotomy) in the stomach wall during NOTES proce
|SOURCE USGI Medical, Inc.|
Copyright©2008 PR Newswire.
All rights reserved